Herbal product use and menopause symptom relief in primary care patients: A metronet study

Journal of Women's Health

Volumn 12, Issue 7, 2003, Pages 633-641

  Dailey, Rhonda K ^a   Neale, Anne Victoria ^a   Northrup, Justin ^a   West, Patricia ^a   Schwartz, Kendra L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIVIRUS AGENT; CENTRAL STIMULANT AGENT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; HORMONE; HYPERICUM PERFORATUM EXTRACT; MONOAMINE OXIDASE INHIBITOR; ORAL CONTRACEPTIVE AGENT; PHYTOESTROGEN; WARFARIN;

ADULT; CAUCASIAN; CONTROLLED STUDY; DEMOGRAPHY; DOCTOR PATIENT RELATION; DRUG BLOOD LEVEL; DRUG INFORMATION; DRUG METABOLISM; DRUG POTENTIATION; DRUG USE; ETHNIC DIFFERENCE; FEMALE; FREQUENCY ANALYSIS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; NEGRO; PATIENT ATTITUDE; PERCEPTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SELF MEDICATION; SELF REPORT; SEROTONIN SYNDROME; SYMPTOMATOLOGY; UNITED STATES;

EID: 0142028965     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/154099903322404285     Document Type: Review

References (58)

1. Clinical challenges of perimenopause: Consensus opinion of The North American Menopause Society. Menopause 2000;7:5.
2. World Health Organization. Research on the menopause in the 1990s. Report of a WHO Scientific Group. WHO Tech Rep Ser 1996;866:1.
3. Notelovitz M. Estrogen replacement therapy: Indications, contraindications, and agent selection. Am J Obstet Gynecol 1989;161:1832.
4. Israel D, Youngkin EQ. Herbal therapies for perimenopausal and menopausal complaints. Pharmacotherapy 1997;17:970.
5. Gold EB, Bromberger J, Crawford S, et al. Factors associated with age at natural menopause in a multi-ethnic sample of midlife women. Am J Epidemiol 2001;153:865.
6. U.S. Census Bureau. Projections of the resident population by age, sex, race, and Hispanic origin 1999 to 2100 (NP-D1-A). Washington, DC: U.S. Census Bureau, Population Projections Program, 2000:1.
7. Lock M. Menopause in cultural context. Exp Gerontol 1994;29:307.
8. Fitzpatrick LA. Selective estrogen receptor modulators and phytoestrogens: New therapies for the postmenopausal women. Mayo Clin Proc 1999;74:601.
9. Reynolds RF, Obermeyer CM, Walker AM, Guilbert D. Side effects and sociobehavioral factors associated with the discontinuation of hormone therapy in a Massachusetts health maintenance organization. Menopause 2001;8:189.
10. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321.
11. Seidl MM, Stewart DE. Alternative treatments for menopausal symptoms. Systematic review of scientific and lay literature. Can Fam Phys 1998;44:1299.
12. Kass-Annese B. Alternative therapies for menopause. Clin Obstet Gynecol 2000;43:162.
13. Kaufert P, Boggs PP, Ettinger B, Woods NF, Utian WH. Women and menopause: Beliefs, attitudes, and behaviors. The North American Menopause Society 1997 Menopause Survey. Menopause 1998;5:197.
14. Ramsey LA, Ross BS, Fischer RG. Phytoestrogens and the management of menopause. Adv Nurse Pract 1999;7:26.
15. Hardy ML. Herbs of special interest to women. J Am Pharm Assoc (Wash) 2000;40:234.
16. Linde K, Mulrow CD. St John's wort for depression. Cochrane Database Syst Rev 2000;2:CD000448.
17. Murphy LL, Lee TJ. Ginseng, sex behavior, and nitric oxide. Ann NY Acad Sci 2002;962:372.
18. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998;280:1569.
19. Mar C, Bent S. An evidence-based review of the 10 most commonly used herbs. West J Med 1999;171:168.
20. Astin JA. Why patients use alternative medicine: Results of a national study. JAMA 1998;279:1548.
21. Fugh-Berman A. Clinical trials of herbs. Primary Care 1997;24:889.
22. Nelson L, Perrone J. Herbal and alternative medicine. Emerg Med Clin North Am 2000;18:709.
23. Eliason BC, Kruger J, Mark D, Rasmann DN. Dietary supplement users: Demographics, product use, and medical system interaction. J Am Board Fam Pract 1997;10:265.
24. Boutin PD, Buchwald D, Robinson L, Collier AC. Use of and attitudes about alternative and complementary therapies among outpatients and physicians at a municipal hospital. J Altern Complement Med 2000;6: 335.
25. Johnson EM, Wootton JC, Kimzey R, et al. Use of herbal therapies by adults seen in an ambulatory care research setting: An exploratory survey. J Altern Complement Med 2000;6:429.
26. Eliason BC, Myszkowski J, Marbella A, Rasmann DN. Use of dietary supplements by patients in a family practice clinic. J Am Board Fam Pract 1996;9:249.
27. Planta M, Gundersen B, Petitt JC. Prevalence of the use of herbal products in a low-income population. Fam Med 2000;32:252.
28. Klepser TB, Doucette WR, Horton MR, et al. Assessment of patients' perceptions and beliefs regarding herbal therapies. Pharmacotherapy 2000;20:83.
29. Palinkas LA, Kabongo ML. The use of complementary and alternative medicine by primary care patients. A SURF*NET study. J Fam Pract 2000;49:1121.
30. del Mundo W, Shepherd WC, Marose TD. Use of alternative medicine by patients in a rural family practice clinic. Fam Med 2002;34:206.
31. Kam IW, Dennehy CE, Tsourounis C. Dietary supplement use among menopausal women attending a San Francisco health conference. Menopause 2002;9:72.
32. Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29:25.
33. Alder E. The Blatt-Kupperman menopausal index: A critique. Maturitas 1998;29:19.
34. Henry GT. Practical sampling. Newbury Park, CA.: Sage Publications, Inc., 1990.
35. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351.
36. Maartens LW, Leusink GL, Knottnerus JA, Smeets CG, Pop VJ. Climacteric complaints in the community. Fam Pract 2001;18:189.
37. Oldenhave A, Jaszmann LJ, Haspels AA, Everaerd WT. Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old. Am J Obstet Gynecol 1993;168:772.
38. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: A multicenter, double-blind, randomized, placebo-controlled study. Menopause 2000;7:236.
39. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998;91:6.
40. Scambia G, Mango D, Signorile PG, et al. Clinical effects of a standardized soy extract in postmenopausal women: A pilot study. Menopause 2000;7:105.
41. Nagata C, Takatsuka N, Kawakami N, Shimizu H. Soy product intake and hot flashes in Japanese women: Results from a community-based prospective study. Am J Epidemiol 2001;153:790.
42. Davis SR. Phytoestrogen therapy for menopausal symptoms? There's no good evidence that it's any better than placebo. Br Med J 2001;323:354.
43. Murkies AL, Teede HJ, Davis SR. What is the role of phytoestrogens in treating menopausal symptoms? Med J Aust 2000;173(Suppl):S97.
44. Philipp M, Kohnen R, Hiller KO. Hypericum extract versus imipramine or placebo in patients with moderate depression: Randomised multicentre study of treatment for eight weeks. Br Med J 1999;319:1534.
45. Woelk H. Comparison of St John's wort and imipramine for treating depression: Randomised controlled trial. Br Med J 2000;321:536.
46. Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness of St John's wort in major depression: A randomized controlled trial. JAMA 2001;285:1978.
47. Grube B, Walper A, Wheatley D. St. John's wort extract: Efficacy for menopausal symptoms of psychological origin. Adv Ther 1999;16:177.
48. Liu J, Burdette JE, Xu H, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 2001;49:2472.
49. Amato P, Christophe S, Mellon PL. Estrogenic activities of herbs commonly used as remedies for menopausal symptoms. Menopause 2002;9:145.
50. Wiklund IK, Mattsson LA, Lindgren R, Limoni C. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: A double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. Int J Clin Pharmacol Res 1999; 19:89.
51. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava. Ann Intern Med 2002;136:42.
52. Baime MJ. Review: St. John's wort, ginkgo, saw palmetto, and kava may be effective for some conditions. ACP J Club 2002;137(1):25.
53. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: A review of randomized, controlled trials. Ann Intern Med 2002;137:805.
54. Kolata G. Race to Fill Void in Menopause-Drug Market. New York: NY Times (nytimes.com). Sept. 1, 2002.
55. Durante KM, Whitmore B, Jones CA, Campbell NR. Use of vitamins, minerals and herbs: A survey of patients attending family practice clinics. Clin Invest Med 2001;24:242.
56. Seidl MM, Stewart DE. Alternative treatments for menopausal symptoms. Qualitative study of women's experiences. Can Fam Phys 1998;44:1271.
57. Scott GN, Elmer GW. Update on natural product-drug interactions. Am J Health Syst Pharm 2002;59: 339.
58. Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355:134.